Nomi's growth is the result of our partnerships. We seek strategic partners with a shared vision to create innovative applications and solutions to improve patient adherence. Through collaborations with leading healthcare and technology companies, we bring visibility to medication adherence.
As an official partner of the Verizon Innovation Program, we work closely with Verizon’s wireless certification and engineering teams to certify Nomi’s existing and new sensor applications. Verizon provides our team unparalleled access and support for the best and most reliable connectivity and data.
Diplomat has partnered with SMRxT to begin deploying its Nomi™ medication adherence system. With Nomi, Diplomat can provide immediate clinical interventions with patients and help prevent failed therapy.
Xcenda is a strategic consultancy with more than two decades of experience helping clients transform evidence, policy insights, and market intelligence into effective global market access strategies.
Florida Hospital, a part of Adventist Health, is one of the nation’s largest not-for-profit healthcare providers with 22 campuses throughout Florida. By collaborating with lab engineers at Florida Hospital’s ISA Prototyping Lab, we can rapidly print, test, and iterate new prototypes within days. We also created a medication adherence pilot program with Florida Hospital to monitor specific medication therapies.
Mail-Meds Clinical Pharmacy is the industry leader and the authority in Adherence Pharmacy. Using Nomi will complement existing adherence programs for high risk patients.
IQ Orlando helped us relocate our headquarters to Orlando, FL. Their collaborative environment and strategic resources, such as R&D, economic development, and clinical validation, inspire us to create the next innovation in healthcare. IQ Orlando was founded by Florida Hospital, Tavistock Group, AHG Group, and the University of Central Florida.
With over 135 applicants, SMRxT was one of 11 chosen companies to participate in the 2016 Healthbox Florida Studio in partnership with GuideWell Innovation. This eight-week studio helped us refine our value proposition, diagnose critical business needs, and develop a go-to-market strategy.
Through this partnership, Aerosonix provides expertise and resources to help us design new medication delivery devices and future applications of Nomi.